市场调查报告书
商品编码
1468012
兽用抗生素和抗菌药物市场:按产品、交付方式、型态、动物类型 - 2024-2030 年全球预测Animal Antibiotics & Antimicrobials Market by Product (Antibiotics, Antimicrobial), Mode of Delivery (Injections, Oral), Form, Type of Animal - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年兽用抗生素市场规模为6.3551亿美元,2024年将达6.6723亿美元,2030年将达9.0984亿美元,复合年增长率为5.25%。
兽用抗生素和抗菌药物包括用于治疗和预防细菌感染以及促进动物健康和福利的物质。由于饮食习惯的改变,全球对动物性蛋白质的需求不断增长,推动了市场的发展。集约化畜牧业和人们对牲畜疾病预防重要性的认识不断提高,导致抗生素使用量增加。此外,兽医保健的进步以及对提高牲畜整体生产力的关注进一步推动了动物健康领域对抗生素和抗菌药物的需求。对抗菌素抗药性(AMR)的担忧已成为一个主要问题,因为抗生素的过度使用会导致抗药性细菌的产生。监管限制和采取更永续的农业实践正在导致畜牧生产中某些抗生素的使用减少。传统抗生素的抗生素替代品(例如益生菌和植物源)的发展趋势不断增长,为动物健康领域的创新提供了机会。此外,对疫苗和生物安全实践等预防措施的日益关注为兽用抗生素和抗菌药物市场的持续成长提供了机会。
主要市场统计 | |
---|---|
基准年[2023] | 63551万美元 |
预测年份 [2024] | 66723万美元 |
预测年份 [2030] | 9.0984亿美元 |
复合年增长率(%) | 5.25% |
产品预防和治疗疾病对抗生素的需求不断增加
抗生素在动物保健中发挥重要作用,并用于多种目的,包括疾病预防、治疗和促进生长。兽医学中最常使用的抗生素是四环霉素、青霉素类、磺胺类药物和大环内酯类。抗菌剂是一种破坏或抑制动物体内微生物生长的药物。这些药物包括抗生素、抗霉菌药、抗原虫药和抗病毒药物。其应用涵盖酪农、家禽、养猪和水产养殖等多个领域,确保动物健康和福利,并减轻感染疾病的影响。
给药方式:由于它是一种非侵入性操作,因此口服给药的趋势不断增加。
注射是兽医学中常用且有效的给药方法,因为它是一种合理的给药方法,并且可以直接吸收到血液中。这种给药方法可绕过胃肠道,通常可以更快地起效。抗生素(例如青霉素和阿莫西林)和抗病毒药物(例如磷酸奥司他韦)通常透过注射给药,以实现有针对性的快速作用。口服兽用抗生素和抗菌剂是最非侵入性、最方便的给药方法。其主要优点是易于管理,特别适合医疗技能最低的小规模农民和宠物饲主。
增加对严重型态感染疾病的动物使用抗菌解决方案
粉剂和锭剂是兽用抗生素和抗菌剂的常见固态形式。它因其最佳的稳定性、成本效益和精确的剂量而广受欢迎。由于它是与饮用水或饲料混合口服给药,因此在兽医诊所使用很方便。抗菌液通常透过相关途径输送,例如口服、乳房内和肠胃外给药。它可以治疗多种细菌感染疾病,并提供即时作用和快速吸收。此溶液的剂量可以轻鬆修改,从而可以根据不同动物的需求轻鬆制定个人化的治疗计划。
动物类型伴同性动物对抗生素和抗菌药物来控制细菌感染疾病的需求正在增长
包括猫在内的伴同性动物容易受到多种细菌感染疾病,其表现形式多种多样,包括尿道感染和猫抓病。阿莫西林和多西环素等抗生素因其广谱抗菌特性而被广泛使用。兽医经常开抗生素治疗狗的细菌感染,例如恩诺沙星或阿莫西林。治疗的常见疾病包括皮肤感染疾病、尿道感染和呼吸道疾病。马科医学常用的抗生素包括青霉素、庆大霉素和四环霉素,用于治疗肺炎、皮肤感染疾病和再生性贫血等疾病。施用正确的剂量对于防止微生物抗药性至关重要。抗生素对于牛健康管理至关重要。四环霉素和磺胺类药物抗生素通常用于预防牛的呼吸道疾病和乳房炎。滥用抗生素会导致抗菌素抗药性和食物链污染。生猪生产中常使用抗生素,包括林可霉素和四环霉素,以预防猪痢疾和肺炎等疾病。保持负责任地使用抗生素对于确保食品安全至关重要。恩诺沙星、阿莫西林和多西环素常用于家禽养殖,用于治疗和预防禽霍乱、传染性支气管炎和球虫等疾病。
区域洞察
在美洲,集中畜牧业和对动物福利的日益重视正在推动兽用抗生素和抗菌药物市场的发展。对动物产品的需求不断增加,人们对牲畜疾病预防的认识不断提高,促进了抗生素在该地区的普及。先进的兽医医疗基础设施和严格的法规进一步塑造了这一格局,北美和南美国家积极为市场格局的扩大做出贡献。在亚太地区,由于对动物性蛋白质的需求不断增加,兽用抗生素和抗菌药物市场正在经历显着增长,特别是在中国和印度等国家。畜牧业的扩张以及对改善动物健康和生产力的日益关注正在推动抗生素在该地区的应用。在欧洲、中东和非洲地区,有关牲畜使用抗生素的严格规定正在影响兽用抗生素市场,特别是在欧洲国家。对永续农业实践的重视以及对抗菌素抗药性日益增长的担忧也有助于塑造市场动态。此外,由于都市化程度的提高和饮食习惯的改变,中东和非洲的畜牧业活动正在扩大。欧洲、中东和非洲地区在引导世界负责任、有效使用兽用抗生素和抗菌药物方面发挥着至关重要的作用。
FPNV定位矩阵
FPNV定位矩阵对于评估兽用抗生素和抗菌药物市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对兽用抗生素和抗生素市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.兽用抗生素/抗菌药市场规模及预测如何?
2.在兽用抗生素和抗生素市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.兽用抗生素/抗菌药市场的技术趋势和法规结构是什么?
4.兽用抗生素/抗生素市场主要供应商的市场占有率是多少?
5. 进入兽用抗生素/抗菌药物市场的适当型态和策略性手段是什么?
[190 Pages Report] The Animal Antibiotics & Antimicrobials Market size was estimated at USD 635.51 million in 2023 and expected to reach USD 667.23 million in 2024, at a CAGR 5.25% to reach USD 909.84 million by 2030.
Animal antibiotics & antimicrobials include substances used to treat and prevent bacterial infections in animals, promoting their health and welfare. The rising global demand for animal protein, driven by changing dietary patterns, is driving the market. The intensification of animal farming and increased awareness of the importance of preventing diseases in livestock contribute to the growing usage of antibiotics. Additionally, advancements in veterinary healthcare and a focus on improving overall animal productivity further propel the demand for antibiotics & antimicrobials in the animal health sector. Concerns over antimicrobial resistance (AMR) pose a significant challenge, as the overuse of antibiotics can lead to the development of resistant strains of bacteria. Regulatory restrictions and a push towards more sustainable farming practices contribute to the restraint on the use of certain antibiotics in animal agriculture. The growing trend toward the development of alternatives to traditional antibiotics, such as probiotics and phytogenics, presents an opportunity for innovation in the animal health sector. Furthermore, increased focus on preventive measures, such as vaccines and biosecurity practices, offers opportunities for sustainable growth in the animal antibiotics & antimicrobials market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 635.51 million |
Estimated Year [2024] | USD 667.23 million |
Forecast Year [2030] | USD 909.84 million |
CAGR (%) | 5.25% |
Product: Growing need for antibiotics for disease prevention and treatment
Antibiotics present a significant component in animal healthcare, deployed for a myriad of purposes, including disease prevention, treatment, and growth promotion. The most commonly used antibiotics in the animal health sector are tetracyclines, penicillins, sulfonamides, and macrolides. Antimicrobials are agents that destroy or inhibit the growth of microorganisms in animals. These include antibiotics, antifungals, antiprotozoals, and antivirals. Their application spans various segments, including dairy, poultry, swine, and aquaculture, to ensure the health and welfare of animals and to mitigate the impacts of infectious diseases.
Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure
Injection is a common and effective method of drug delivery in veterinary medicine due to its streamlined administration and direct absorption into the bloodstream. This mode of delivery bypasses the digestive barriers and often results in a faster onset of medical action. Antibiotics such as penicillin, amoxicillin, and antivirals such as oseltamivir phosphate are often administered via injections for targeted, immediate relief. Oral delivery of antibiotics & antimicrobials for animals is the most non-invasive and convenient mode of delivery. Its main advantage lies in its ease of administration, particularly suitable for small scale farmers or pet owners with minimal medical proficiency.
Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
Powders & tablets are common solid dosage forms for animal antibiotics and antimicrobials. They have gained traction due to their optimal stability, cost-effectiveness, and the potential for precision dosing. They are administered orally in drinking water or feed, making them a convenient option for veterinary use. Antimicrobial solutions are typically provided through allied routes, including oral, intramammary, or parenteral administration. They cater to a broad spectrum of bacterial infections and provide instant relief and rapid absorption. Solutions can be easily modified in terms of dosage, facilitating personalized treatment plans based on varying animal needs.
Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections
Companion animals including cats are prone to various bacterial infections, which manifest in different forms of diseases such as urinary tract infection and cat-scratch disease. Antibiotics such as amoxicillin and doxycycline are commonly used for their broad-spectrum antimicrobial properties. Veterinarians often prescribe antibiotics including enrofloxacin and amoxicillin for bacterial infections in dogs. Some common illnesses treated include skin infections, urinary tract infections, and respiratory diseases. Common antibiotics used in equine medicine include penicillin, gentamicin, and oxytetracycline to treat ailments such as pneumonia, skin infections, and regenerative anemia. It's crucial to administer the correct dosage to prevent microbial resistance. Antibiotics are vital for cattle health management. Tetracyclines and sulfonamides are frequently used for the prevention of bovine respiratory disease and mastitis. Misuse of antibiotics can lead to antimicrobial resistance and food-chain contamination. Frequent use of antibiotics in swine production, including lincomycin and chlortetracycline, is common for the prevention of diseases such as swine dysentery and pneumonia. It's essential to maintain the responsible use of antibiotics to ensure food safety. Enrofloxacin, amoxicillin, and doxycycline are typically used in poultry farming for the treatment and prevention of diseases such as avian cholera, infectious bronchitis and coccidiosis.
Regional Insights
In the Americas, the market for animal antibiotics & antimicrobials is driven by the significant presence of intensive animal farming practices and a growing emphasis on animal welfare. The rising demand for animal-derived products, coupled with increased awareness of disease prevention in livestock, contributes to the widespread use of antibiotics in the region. Advanced veterinary healthcare infrastructure and stringent regulations further shape the landscape, with North and South American countries actively contributing to the expansion of the animal antibiotics & antimicrobials market. In the Asia-Pacific region, the animal antibiotics & antimicrobials market experiences substantial growth due to the increasing demand for animal protein, particularly in countries including China and India. The expansion of the livestock industry, coupled with a rising focus on improving animal health and productivity, drives the adoption of antibiotics in the region. Within the EMEA region, the market for animal antibiotics & antimicrobials is influenced by stringent regulations on antibiotic use in livestock, particularly in European countries. The emphasis on sustainable farming practices and heightened concerns about antimicrobial resistance contribute to shaping the market dynamics. Additionally, the Middle East and Africa witness growth in animal farming activities, driven by increasing urbanization and dietary changes. The EMEA region plays a pivotal role in steering the global direction of responsible and effective use of animal antibiotics & antimicrobials.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Animal Antibiotics & Antimicrobials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Antibiotics & Antimicrobials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Animal Antibiotics & Antimicrobials Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Antibiotics & Antimicrobials Market?
3. What are the technology trends and regulatory frameworks in the Animal Antibiotics & Antimicrobials Market?
4. What is the market share of the leading vendors in the Animal Antibiotics & Antimicrobials Market?
5. Which modes and strategic moves are suitable for entering the Animal Antibiotics & Antimicrobials Market?